|Bid||78.86 x 800|
|Ask||79.49 x 800|
|Day's Range||76.91 - 79.56|
|52 Week Range||56.91 - 84.38|
|Beta (3Y Monthly)||0.78|
|PE Ratio (TTM)||56.33|
|Earnings Date||Apr 24, 2019|
|Forward Dividend & Yield||0.80 (0.96%)|
|1y Target Est||85.75|
Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CONMED Corporation (CNMD) today announced an amended start time for its Annual Meeting of Shareholders. As previously announced, the meeting will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday, May 22, 2019. CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! In 2014 Curt Hartman was appointed CEO of CONMED Corporation (NASDAQ:CNMD). First, this article will compare CEO c...
CONMED Corporation (CNMD) today announced that it will report financial results for the first quarter of 2019 after the market close on Wednesday, April 24, 2019. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 844-889-7792 (domestic) or 661-378-9936 (international) and refer to the passcode 9275258.
Conmed Corp NASDAQ/NGS:CNMDView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low and declining Bearish sentimentShort interest | PositiveShort interest is low for CNMD with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on March 18. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $766 million over the last one-month into ETFs that hold CNMD are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
CONMED Corporation today announced that its Annual Meeting of Shareholders will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday, May 22, 2019, at 3:30 p.m.
Inogen (INGN) gains from solid direct-to-consumer revenues in Q4; strong business-to-business revenues in the United States.
OPKO Health (OPK) witnesses sluggishness in the Products revenues segment in Q4. However, contribution from RAYALDEE has been significant in the quarter.
The roll-out of t:slim X2 with Basal-IQ technology, increased supply capacity and renewal sales, as well as the international launch, drive Tandem's (TNDM) Q4 revenues.